申请人:Pfizer Inc.
公开号:US10966980B2
公开(公告)日:2021-04-06
Described herein are pyrrolo2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing them, and therapeutic uses thereof.
本文描述了吡咯并2,3-d}嘧啶衍生物、它们作为 Janus 激酶 (JAK) 抑制剂的用途、含有它们的药物组合物及其治疗用途。